...
首页> 外文期刊>Biochemistry >IDENTIFICATION OF A PLASMINOGEN BINDING REGION IN STREPTOKINASE THAT IS NECESSARY FOR THE CREATION OF A FUNCTIONAL STREPTOKINASE-PLASMINOGEN ACTIVATOR COMPLEX
【24h】

IDENTIFICATION OF A PLASMINOGEN BINDING REGION IN STREPTOKINASE THAT IS NECESSARY FOR THE CREATION OF A FUNCTIONAL STREPTOKINASE-PLASMINOGEN ACTIVATOR COMPLEX

机译:鉴定链激酶中溶酶原结合区对于创建功能性链激酶-纤溶酶原激活物复合物是必要的

获取原文
获取原文并翻译 | 示例

摘要

Streptokinase is a plasminogen activator widely used to treat patients with myocardial infarction. However, streptokinase is not a protease, and must first bind and interact with plasminogen to form an enzymatic complex. By measuring the binding of recombinant streptokinase fragments to plasminogen, we have sought, first, to identify a plasminogen binding region in streptokinase and, second, to explore the relation between binding (via this region) and the generation of a functional streptokinase-plasminogen activator complex. Recombinant streptokinase bound in a saturable and specific manner to human Glu-plasminogen with a dissociation constant of 4.2 x 10(-10) M, Recombinant streptokinase fragments spanning amino acids 1-127 and 1-253 could not be shown to bind to Glu-plasminogen, whereas fragments spanning amino acids 1-352, 120-352, and 244-414 bound tightly to plasminogen and each fragment completely inhibited the binding of full-length streptokinase to plasminogen. Although these latter streptokinase fragments formed a complex with plasminogen, enzymatic assays indicated that none of them was capable of generating an active site. When the streptokinase region shared by these three fragments, spanning residues 244-352, was expressed, it also bound plasminogen and competitively inhibited the formation of a functional plasminogen activator complex by full-length streptokinase, Taken together, these data indicate that streptokinase binds to plasminogen with high affinity, that a primary binding region for plasminogen is located within amino acids 244-352, and that binding via this region is necessary for the generation of a functional plasminogen activator complex.
机译:链激酶是一种纤溶酶原激活剂,广泛用于治疗心肌梗塞患者。但是,链激酶不是蛋白酶,必须首先与纤溶酶原结合并相互作用才能形成酶复合物。通过测量重组链激酶的片段与纤溶酶原的结合,我们寻求首先鉴定链激酶中的纤溶酶结合区域,其次,探索结合(通过该区域)与功能性链激酶-纤溶酶原激活物的产生之间的关系。复杂。重组链激酶以可饱和且特异的方式与人Glu-纤溶酶原结合,解离常数为4.2 x 10(-10)M,跨越氨基酸1-127和1-253的重组链激酶片段无法显示与Glu-纤溶酶原,而跨越氨基酸1-352、120-352和244-414的片段与纤溶酶原紧密结合,并且每个片段都完全抑制了全长链激酶与纤溶酶原的结合。尽管这些后来的链激酶酶片段与纤溶酶原形成了复合物,但是酶法测定表明它们均不能产生活性位点。当表达这三个片段(跨越残基244-352)共有的链激酶区域时,它也结合了纤溶酶原,并通过全长链激酶酶竞争性地抑制了功能性纤溶酶原激活物复合物的形成。综上所述,这些数据表明,链激酶与纤溶酶原具有高亲和力,纤溶酶原的主要结合区位于氨基酸244-352内,并且通过该区域的结合对于产生功能性纤溶酶原激活物复合物是必需的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号